Organogenesis Holdings Overview

  • Founded
  • 1985

Founded
  • Status
  • Public

  • Employees
  • 950

Employees
  • Stock Symbol
  • ORGO

Stock Symbol
  • Investments
  • 5

  • Share Price
  • $6.19

  • (As of Friday Closing)

Organogenesis Holdings General Information

Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 85 Dan Road
  • Canton, MA 02021
  • United States
+1 (781) 000-0000

Organogenesis Holdings Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Organogenesis Holdings Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.19 $5.92 $4.62 - $17.50 $799M 129M 1.09M $0.66

Organogenesis Holdings Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 999,565 1,198,520 1,039,817 576,879
Revenue 463,624 468,059 338,298 260,981
EBITDA 76,987 87,698 37,226 (19,737)
Net Income 85,046 94,902 17,234 (38,709)
Total Assets 436,272 443,259 290,218 220,687
Total Debt 130,194 132,303 84,771 100,606
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Organogenesis Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Organogenesis Holdings‘s full profile, request access.

Request a free trial

Organogenesis Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercializa
Biotechnology
Canton, MA
950 As of 2021
00000
00000000 00000

000000

luptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pro
0000000000000
Marietta, GA
000 As of 0000
00000
000000000 00000

000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000 000000000
San Diego, CA
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Organogenesis Holdings Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mimedx Corporation Marietta, GA 000 00000 000000000 00000
00000000 Formerly VC-backed San Diego, CA 00 000.00 000000000 000.00
000000000 Corporation Melbourne, Australia 00 00000 000000000 00000
00000000 Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
00000000 Formerly VC-backed Durham, NC 000 00000 000000000 00000
You’re viewing 5 of 22 competitors. Get the full list »

Organogenesis Holdings Patents

Organogenesis Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210311022-A1 Methods, kits and compositions for characterizing an anti-inflammatory response of a product Pending 27-Mar-2020 00000000000
US-20200147144-A1 Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases Pending 31-Mar-2015 000000000
US-20160287641-A1 Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases Granted 31-Mar-2015 000000000
US-10576107-B2 Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases Active 31-Mar-2015 000000000 0
US-20210393702-A1 Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases Pending 03-Mar-2015 A61K35/50
To view Organogenesis Holdings’s complete patent history, request access »

Organogenesis Holdings Executive Team (10)

Name Title Board Seat Contact Info
Gary Gillheeney Sr. Director, President and Chief Executive Officer
David Francisco Chief Financial Officer
Patrick Bilbo Chief Operating Officer, Operations
Brian Grow Executive
Lori Freedman JD General Counsel, Legal & Vice President
You’re viewing 5 of 10 executive team members. Get the full list »

Organogenesis Holdings Board Members (12)

Name Representing Role Since
0000 0000 Organogenesis Holdings Chairman & Board Member 000 0000
000000 000000000 Organogenesis Holdings Board Member 000 0000
00000 00000 Organogenesis Holdings Board Member 000 0000
0000 0000000000 00. Organogenesis Holdings Director, President and Chief Executive Officer 000 0000
00000 00000000 Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Organogenesis Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Organogenesis Holdings Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 17-Sep-2020 0000000000 0000 Medical Supplies 0000 0000
000000 000000 10-Dec-2018 0000000000 Special Purpose Acquisition Company (SPAC) 0000 0000
000000 000000 24-Mar-2017 0000000000 000.00 Surgical Devices 0000 0000
00000 (000000 17-Jan-2014 0000000000 00000 Pharmaceuticals
NanoMatrix 25-Feb-2008 Merger/Acquisition Biotechnology 00000 000
To view Organogenesis Holdings’s complete acquisitions history, request access »

Organogenesis Holdings Subsidiaries (2)

Company Name Industry Location Founded
NuTech Medical Surgical Devices Birmingham, AL 1994
000 00000000000 Medical Supplies Largo, FL
To view Organogenesis Holdings’s complete subsidiaries history, request access »